Should retatrutide receive a positive regulatory decision, it would then be subject to a health technology appraisal (HTA) by NICE (National Institute for Health and Care Excellence) to determine its clinical and cost-effectiveness relative to existing treatments
Compounding is no longer limited to rare use cases
These promoter regions act like dimmer switches for gene expression, and by binding here, Epitalon appears to gently dial up telomerase gene transcription without altering the DNA itself
It is not used for treating type 1 diabetes or for people with diabetic ketoacidosis
But as with any medical revolution, the meteoric rise of these drugs has brought a complex mix of life-changing benefits, dangerous side effects, and a booming, highly illegal shadow market
Sturgeon C, Lan J, Fasano A